LFB_Group is a renowned brand specializing in the production and distribution of biological medicines. With a strong international presence, LFB_Group offers therapeutic solutions for rare immune disorders, such as Von Willebrand-Syndrome and hemophilia. As a trusted partner of international patient organizations, LFB_Group is dedicated to providing patients with the highest level of care and support.

They prioritize patient safety and place a strong emphasis on innovative and technologically advanced treatments. LFB_Group conducts clinical studies to continually enhance their therapeutic offerings and improve patient outcomes. Their commitment to the environment is evident in their responsible use of resources as an international biopharmaceutical manufacturer.

Healthcare professionals can access exclusive materials and information on immunology and hemostasis through their secure online platform. LFB_Group is committed to ensuring that patients with severe and rare diseases receive the best possible treatment and care